Lead sponsor
Shanghai Hengrui Pharmaceutical Co., Ltd.
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
0
Ongoing
142
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
2
Phase 2
1
Trials by status
Completed
2
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease PatientsMCI due to ADPh 2Terminated46
A Study of SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's DiseaseMCI due to ADPh 1Completed33